OncoMed Pharmaceuticals Inc (NASDAQ:OMED) - Share price - Overview

Stock Report

OncoMed Pharmaceuticals Inc OMED

Last Price
$4.47

Day Change
0.06|1.36%

As of 22/09/2017
16:00:00 EDT | USD
Minimum 15 Minutes Delay.

Last Close4.41
Day Range4.35 - 4.52
Mkt Cap168.20Mil
52-Wk Range2.91 - 12.58
Yield %-
ISINUS68234X1028
Volume140,920
P/E-1.91
P/S6.64
P/CF-1.54

Share Price

Financials
201420152016
More ...
Income Statement
Revenue39.5625.9025.15
Operating Income-50.62-85.56-103.39
Net Income-50.01-85.41-103.10
Basic EPS-1.69-2.84-3.14
Avg. Diluted Shares Outstanding303033
Balance Sheet
Current Assets240.81231.26189.58
Non Current Assets7.036.635.90
Total Assets247.84237.89195.48
Current Liabilities38.5552.6455.85
Total Liabilities171.48234.34218.51
Total Equity76.373.55-23.03
Cash Flow
Operating Cash Flow-84.51-75.14-36.94
Capital Expenditure-1.81-1.36-1.16
Free Cash Flow-86.32-76.50-38.09

In millions, except "Basic EPS". Currency is USD.

Company Profile

OncoMed Pharmaceuticals Inc is a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology product candidates.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

122
Key Stats
More ...
Price/Earning TTM-1.88
Price/Book-3.09
Price/Sales TTM6.55
Rev Growth (3 year avg)-12.68
EPS Growth (3 year avg)-
Operating Margin % TTM-411.03
Net Margin % TTM-409.90
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.